Illumina Files 8-K on Financials

Ticker: ILMN · Form: 8-K · Filed: 2025-01-14T00:00:00.000Z

Sentiment: neutral

Topics: financial-reporting, 8-k

Related Tickers: ILMN

TL;DR

Illumina dropped its 8-K on Jan 14th - check the financials!

AI Summary

On January 14, 2025, Illumina, Inc. filed an 8-K report detailing its financial condition and results of operations. The filing includes financial statements and exhibits, providing an update on the company's performance.

Why It Matters

This filing provides investors with crucial, up-to-date information on Illumina's financial health and operational performance, impacting investment decisions.

Risk Assessment

Risk Level: low — This is a routine financial filing and does not indicate any immediate or significant risks.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing by Illumina, Inc.?

The primary purpose of this 8-K filing is to report on Illumina, Inc.'s results of operations and financial condition, and to provide financial statements and exhibits.

What is the date of the earliest event reported in this filing?

The date of the earliest event reported in this filing is January 14, 2025.

What is Illumina, Inc.'s Commission File Number?

Illumina, Inc.'s Commission File Number is 001-35406.

In which state was Illumina, Inc. incorporated?

Illumina, Inc. was incorporated in Delaware.

What is the address of Illumina, Inc.'s principal executive offices?

The address of Illumina, Inc.'s principal executive offices is 5200 Illumina Way, San Diego, CA 92122.

From the Filing

0001110803-25-000009.txt : 20250114 0001110803-25-000009.hdr.sgml : 20250114 20250114090313 ACCESSION NUMBER: 0001110803-25-000009 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20250114 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250114 DATE AS OF CHANGE: 20250114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ILLUMINA, INC. CENTRAL INDEX KEY: 0001110803 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 330804655 STATE OF INCORPORATION: DE FISCAL YEAR END: 1229 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35406 FILM NUMBER: 25527882 BUSINESS ADDRESS: STREET 1: 5200 ILLUMINA WAY CITY: SAN DIEGO STATE: CA ZIP: 92122 BUSINESS PHONE: 8582024500 MAIL ADDRESS: STREET 1: 5200 ILLUMINA WAY CITY: SAN DIEGO STATE: CA ZIP: 92122 FORMER COMPANY: FORMER CONFORMED NAME: ILLUMINA INC DATE OF NAME CHANGE: 20000331 8-K 1 ilmn-20250114.htm 8-K ilmn-20250114 0001110803 FALSE 0001110803 2025-01-14 2025-01-14 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form  8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 14, 2025 Illumina, Inc. (Exact name of registrant as specified in its charter) 001-35406 (Commission File Number) Delaware   33-0804655 (State or other jurisdiction of incorporation)   (I.R.S. Employer Identification No.) 5200 Illumina Way , San Diego , CA 92122 (Address of principal executive offices) (Zip code) ( 858 )  202-4500 (Registrant’s telephone number, including area code) N/A (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.01 par value ILMN The NASDAQ Global Select Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐      If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13a of the Exchange Act. o      TABLE OF CONTENTS Item 2.02 Results of Operations and Financial Condition Item 9.01 Financial Statements and Exhibits SIGNATURES Exhibit Index Table of Contents Item 2.02 Results of Operations and Financial Condition. On January 14, 2025, in advance of a public webcast presentation at the J.P. Morgan Healthcare Conference in San Francisco, California, Illumina, Inc. (the "Company") issued a press release regarding the Company's unaudited preliminary financial results for the fourth quarter and fiscal year ended December 29, 2024. The webcast is accessible through the Investor Relations section

View on Read The Filing